M. Kathleen Behrens, Director at Sarepta Therapeutics, Inc. (SRPT), bought 75,000 shares at $16.54 ($1.2M) on 2016-03-14, disclosed to the SEC on 2016-03-16.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $16.54 | 65,000 | $1.1M | 88.1% |
| 2 | $14.54 | 10,000 | $145K | 11.9% |
| Total | $16.27 avg | 75,000 | $1.2M | 100% |
| Filing → |
| IGMS | BUY | 2022-04-04 | $1.4M | — | Filing → |
| SRPT | SELL | 2021-03-10 | $429K | — | Filing → |
| IGMS | BUY | 2020-12-15 | $3.0M | — | Filing → |